MEVES PHARMACEUTICALS, INC.
Profile
Company Names
MEVES PHARMACEUTICALS, INC.
Addresses
57 WEST 57TH ST., NEW YORK, NY 10019
Phone Numbers
510-375-1669
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2016
State Incorporated:
DELAWARE
Total Amount Raised:
$10,905,005.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-03-15
$10,905,005.00
$30,905,005.00
$20,000,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
BEN
AUSPITZ
DIRECTOR
LIGOCYTE PHARMACEUTICALS INC
| ULTRAGENYX PHARMACEUTICAL INC.
| SYMBIOMIX THERAPEUTICS, LLC
| UNUM THERAPEUTICS, INC.
| PRECISION BIOSCIENCES INC
| COMPASS THERAPEUTICS LLC
| CHECKMATE PHARMACEUTICALS, INC.
| INDALO THERAPEUTICS, INC.
| MEVES PHARMACEUTICALS, INC.
| ZERO POINT FIVE THERAPEUTICS, INC.
| ANTLIA BIOSCIENCE, INC.
RISHI
GUPTA
DIRECTOR
GELESIS INC
| SIENTRA, INC.
| AVITIDE, INC.
| SYMBIOMIX THERAPEUTICS, LLC
| DIMENSION THERAPEUTICS, INC.
| MEVES PHARMACEUTICALS, INC.
| ATTENUA, INC.
| TURNSTONE BIOLOGICS CORP.
| GOLDEN TEAK CAPITAL L.P.
| NEUROPACE INC
| VERONA PHARMA PLC
| CHARM THERAPEUTICS INC.
| DELFI DIAGNOSTICS, INC.
| AER THERAPEUTICS, INC.
| HELICORE BIOVENTURES I, INC.
| ENLIVEN THERAPEUTICS, INC.
| WILSHIRE SELECTIVE OPPORTUNITIES PROGRAM SPC - WILSOP SEGREGATED PORTFOLIO 5
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
